Frank‐Peter Theil - Concepedia

Author

Frank‐Peter Theil

Roche (Switzerland)ORCID

Also Known As

F P Theil, F. Theil, F.-P. Theil, F.‐P. THEIL, Frank-Peter Theil, Frank‐Peter Theil, Honghui Zhou

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Roche (Switzerland)Kaiser Permanente South San Francisco Medical Center UCB Pharma (Belgium)Genentech Dynamic Research (United States)

About

Frank‐Peter Theil is an author at Roche (Switzerland) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	2.5K
2	Engineering	2	2	49
3	Health Sciences	1	1	209
4	Natural Sciences	1	1	55
5	Allergy	1	1	270

Frank‐Peter Theil

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Prediction of Pharmacokinetics Prior to In Vivo Studies. 1. Mechanism‐Based Prediction of Volume of Distribution Patrick Poulin, Frank‐Peter Theil Journal of Pharmaceutical Sciences Molecular PharmacologyPharmacokinetic ModelingPharmacodynamicsVivo StudiesPharmacokinetics Prior	2002	556
A Priori Prediction of Tissue:Plasma Partition Coefficients of Drugs to Facilitate the Use of Physiologically‐Based Pharmacokinetic Models in Drug Discovery Patrick Poulin, Frank‐Peter Theil Journal of Pharmaceutical Sciences Pharmacokinetic ModelingPharmacodynamicsPharmacological StudyPharmacometricsDrug Discovery	2000	419
Prediction of Pharmacokinetics Prior to In Vivo Studies. II. Generic Physiologically Based Pharmacokinetic Models of Drug Disposition Patrick Poulin, Frank‐Peter Theil Journal of Pharmaceutical Sciences Physiologically Based PharmacokineticsPharmacokinetic ModelingPharmacodynamicsPharmacological StudyDrug Disposition	2002	297
Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data Rong Deng, Suhasini Iyer, Frank‐Peter Theil, mAbs Therapeutic Drug MonitoringTranslational MedicineAllergyPreclinical Drug EvaluationHuman Pharmacokinetics	2011	270
A strategy for risk mitigation of antibodies with fast clearance Isidro Hötzel, Frank‐Peter Theil, L. Bernstein, mAbs	2012	246
Prediction of adipose tissue: Plasma partition coefficients for structurally unrelated drugs Patrick Poulin, Kerstin Schoenlein, Frank‐Peter Theil Journal of Pharmaceutical Sciences ObesityMetabolic SyndromeBody CompositionUnrelated DrugsMetabolic Disorder	2001	209
Impact of Drug Conjugation on Pharmacokinetics and Tissue Distribution of Anti-STEAP1 Antibody–Drug Conjugates in Rats C. Andrew Boswell, Eduardo E. Mundo, Crystal Zhang, Bioconjugate Chemistry NanotherapeuticsLocal PharmacologyImmunologyCellular PharmacologyPharmacotherapy	2011	200
Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration Yanan Zheng, Devin B. Tesar, Lisa J. Benincosa, mAbs Immunocytochemical TechniqueImmunologyPharmacotherapyDermatologyImmunotherapy	2012	135
Antitumor Activity of Targeted and Cytotoxic Agents in Murine Subcutaneous Tumor Models Correlates with Clinical Response Harvey Wong, Edna F. Choo, Bruno Alicke, Clinical Cancer Research	2012	128
Development of a novel method for predicting human volume of distribution at steady-state of basic drugs and comparative assessment with existing methods Patrick Poulin, Frank‐Peter Theil Journal of Pharmaceutical Sciences Comparative AssessmentHuman VolumePharmacokinetic ModelingPreclinical Drug EvaluationMedicine	2009	112

Page 1